FDA Brief

Warning letters Food

FDA warning letter to

Nara Company Ltd.

High riskIssued Feb 7, 2023Posted Mar 28, 2023Center for Food Safety and Applied Nutrition (CFSAN)

FDA says Nara Company's seafood HACCP plan is inadequate and makes fish fillets adulterated.

What happened

FDA conducted a Foreign Regulatory Assessment of Nara Company Ltd.'s seafood processing facility in Japan on September 7, 2022, and issued an FDA 483 listing observations. FDA found serious violations of the seafood HACCP regulation, including missing food safety hazards and inadequate critical limits. The company responded on October 7, 2022, with a revised HACCP plan dated September 19, 2022, but FDA found the response inadequate.

What FDA found

  1. The revised HACCP plan did not list pathogenic bacteria growth and toxin formation or metal inclusion as food safety hazards.

    21 CFR 123.6(a) and (c)(1)
  2. The critical limits for unapproved aquaculture drugs were inadequate because oxytetracycline is not approved for buri (Seriola quinqueradiata).

    21 CFR 123.3(c)(3)
  3. The critical limits for scombrotoxin (histamine) formation were inadequate and lacked harvest vessel records or histamine testing, sensory examination, internal temperature measurements, and transit control.

    21 CFR 123.3(c)(3)
  4. The critical limits for Clostridium botulinum and undeclared allergens were inadequate, including no critical limit to ensure labels are properly applied to each finished package.

    21 CFR 123.3(c)(3)

What FDA wants

FDA tells the company to respond in writing within 15 working days of receipt, outline specific corrections, and include a revised HACCP plan plus 5 consecutive days of completed monitoring records for 5 production date codes; if corrections cannot be completed, the company must explain the delay and state when it will correct remaining violations.

Who should pay attention

  • US importers and distributors of frozen seafood
  • brands buying finished fish products from this processor
  • retailers and foodservice buyers sourcing aquaculture fish

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk